Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization
- Written by PR Newswire
 |
- Process Performance Qualification (PPQ) validates robust manufacturing standards and is crucial for regulatory compliance
- Marks a key step forward for the world's first once-monthly IL-4Rα-targeting antibody therapeutic for Th2-driven diseases, with a strategic focus on entering the American and European markets
SHANGHAI, Jan. 3, 2025 /PRNewswi...
